VAC-18307-71414
2 vaccinations
2 coded responses
9 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 100 / NY
- Registered
- 2021-12-20
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-12-18
Dose 1 — Pfizer-BioNTech
-
2021-12-20
Registered in v-safe
- 2021-12-20
-
2021-12-23
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body achesAdult check-in
-
2021-12-24
Survey response — days 1–6 daily, dose 1MedDRA: Nasal congestion — Feeling: Poor · Fatigue or tiredness · Be unable to work or attend schoolFree text: Stuffy noseMedDRA releases: 2024-11 · check-in free text available
-
2021-12-25
Health check-in — day 7, dose 1Feeling: Poor · Fatigue or tiredness, Diarrhea, Abdominal painAdult check-in
-
2022-01-01
Dose 2 — Pfizer-BioNTech
- 2022-01-10
- 2022-01-15
- 2022-01-22
- 2022-02-07
-
2022-04-02
Survey response — 3 months, dose 2MedDRA: Diarrhoea — Feeling: FairFree text: DiarrheaMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-12-18 | Pfizer-BioNTech | No |
| 2 | 2022-01-01 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 1
Systemic reaction (other): Stuffy nose
Release 11 — 3 months, dose 2
Symptoms: Diarrhea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | · | · | ✓ |
| SRO | Nasal congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release